Skip to main content
Home
Drug Metabolic Roadmap (2024 update)
★
Drug Metabolic Roadmap
★
Drug Metabolite
★
Metabolic Reaction
DME Interactome
Microbiome-DME Interaction
Host Protein-DME Interaction
Xenobiotics-DME Interaction
Download
Help
Drug Information
Drug General Information
Drug ID
D08AIJ
Former ID
DNC011120
Drug Name
ERIODICTYOL
Drug Type
Small molecular drug
Indication
Discovery agent
Investigative
[
531094
]
Formula
C15H12O6
Canonical SMILES
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(C=C3)O)O
InChI
1S/C15H12O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-5,13,16-19H,6H2/t13-/m0/s1
InChIKey
SBHXYTNGIZCORC-ZDUSSCGKSA-N
PubChem Compound ID
11095
Target and Pathway
Target(s)
Cytochrome P450 1B1
Target Info
Inhibitor
[
531094
]
BioCyc Pathway
Superpathway of tryptophan utilization
Superpathway of melatonin degradation
Melatonin degradation I
KEGG Pathway
Steroid hormone biosynthesis
Tryptophan metabolism
Metabolism of xenobiotics by cytochrome P450
Ovarian steroidogenesis
Chemical carcinogenesis
MicroRNAs in cancer
NetPath Pathway
TSH Signaling Pathway
IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
Reactome
Endogenous sterols
WikiPathways
Metapathway biotransformation
Estrogen metabolism
Benzo(a)pyrene metabolism
Tamoxifen metabolism
Tryptophan metabolism
Oxidation by Cytochrome P450
Nuclear Receptors Meta-Pathway
Estrogen Receptor Pathway
Sulindac Metabolic Pathway
Arylhydrocarbon receptor (AhR) signaling pathway
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in epithelium - TarBase
miR-targeted genes in adipocytes - TarBase
Phase 1 - Functionalization of compounds
References
Ref 531094
Bioorg Med Chem. 2010 Sep 1;18(17):6310-5. Epub 2010 Jul 13.Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Ref 531094
Bioorg Med Chem. 2010 Sep 1;18(17):6310-5. Epub 2010 Jul 13.Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
If you find any error in data or bug in web service, please kindly report it to
Dr. Yin
and
Dr. Li
.